Sonnet BioTherapeutics Holdings Inc Sustainability Reports
An oncology-focused biotechnology company developing a platform for biologic medicines of single or bispecific action. The company utilizes its fully human albumin-binding technology to transport biologic medicines to target tissues.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2021 to 2023